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SOUHRN
Kuzenko Y., Romanyuk A.: Epulis gigantocelularis: imunohistochemická analýza MGMT, p53, OPN a MMP-1
Cíl práce: Cílem studie bylo analyzovat expresi MGMT, p53, OPN a MMP-1 u epulis gigantocelularis. 
Materiál a metody: U deseti případů epulis gigantocelularis byla imunohistochemicky hodnocena exprese MGMT, p53, OPN a MMP-1.
Výsledky: Silná pozitivita MGMT v obrovských buňkách byla pozorována v 96,9 ± 0,5 % (P < 0,05). Silná mezenchymální imunoreak-
tivita MMP-1 byla zjištěna u obrovských buněk (75,9 ± 1,33%) a stromatu (54,12 ± 1,36%; P < 0,05). Imunoreaktivita OPN byla naleze-
na u obrovských buněk epulis v 15,77 ± 1,8 %, pozitivita p53 byla zjištěna u 5,67 ± 0,32 % obrovských buněk a 0 % stromatu.
Závěr: MGMT, p53 a OPN mohou hrát důležitou roli v biologii epulis gigantocelularis. Kromě toho, MMP-1 těchto proteáz ve vyšších
hladinách u epulis gigantocelularis může pomoci vysvětlit invazi do kostní matrix.
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SUMMARY
Kuzenko Y., Romanyuk A.: Giant-cell epulis: immunohistochemical analysis of MGMT, p53, OPN and MMP-1
Object: The object of this study was to analyze the expression of MGMT, p53, OPN and MMP-1 in giant-cell epulis.
Methods: 10 giant-cell epulis were evaluated for expression of MGMT, p53, OPN and MMP-1 by immunohistochemistry.
Results: Strong giant-cell positivity for MGMT was observed in 96.9 ± 0.5 % (P < 0.05). Strong mesenchymal immunoreactivity 
for MMP-1 was figured in giant-cell, 75.9 ± 1.33 % and in the stroma 54.12 ± 1.36 % (P < 0.05). Immunoreactivity for OPN was fixed 
in the giant-cell of epulis 15.77 ± 1.8%., positivity for p53 was found in 5.67 ± 0.32 % of giant-cell contrast and in the stroma 0 %.
Conclusion: MGMT, p53 and OPN may play important roles in the biology of giant-cell epulis. Furthermore, theMMP-1 of these pro-
teases at higher levels in giant-cell epulis may help to explain invasion in bone matrix.
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Introduction
Giant-cell epulis is an infrequent reactive, exophytic le -
sion of the oral cavity, also known as osteoclastoma, giant
cell reparative granuloma, peripheral giant cell granuloma
or giant cell hyperplasia.
It usually affects the mandible in 70 % of cases and the
maxilla in the remaining 30 % [1]. Giant-cell epulis is asso-
ciated with perforation of the cortical plate(s) [2]. It is pro-
bably a reactive lesion caused by local irritation or chronic
trauma which hurts connective tissue, periosteum or perio-
dontal membrane [3].
A study by Willing et al [4] says that the stromal cells sec-
rete a variety of cytokines and differentiation factors, inclu-
ding monocyte chemoattractant protein-1 (MCP1), Osteo -
clast differentiation factor (ODF), and Macrophage-colony
stimulating factor (M-CSF). These molecules are monocyte
chemoattractants and are essential for osteoclast differentia-
tion, suggesting that the stromal cell stimulates blood mo-
nocyte immigration into tumour.
Immunohistochemical evaluationby Falaschini S et al [5]
reveals a diffuse presence of CD68 (antigen most widely di-
stributed in monocyte macrophages lineage at various diffe-
rentiation stages as well dendritic cells and osteoclasts) in
a fraction of round mononuclear stromal cells and in mono-
nuclear giant cells. This result confirms that these latter may
derive from osteoclasts, according to previous study [6].
Giant-cell epulis is strongly positive for this antibody
CD34, reaction product is not evident in the lesion within
the aggregations of multinucleate giant cells. This data may
suggest that multinucleate giant cell does not come from en-
dothelial cells of the capillaries [7].
In this study, we tested the hypothesis that p53 (tumor
suppressing protein) is regulated by MGMT (O-6-methyl-
guanine-DNA methyltransferase) in giant-cell epulis.
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MGMT protein acts through a self-destruction mecha-
nism, removing abnormal adducts from the O6 position of
guanine, providing protection from mutagenic agents [8].
Loss of MGMT expression has been associated with ag-
gressive tumor behavior and progression in several types of
neoplasia, including esophageal, hepatocellular, lung, ga-
stric and breast carcinomas [9].
Many types of stress activate p53, including DNA dama-
ge, telomere attrition, oncogene activation, hypoxia and loss
of normal growth and survival signals. These stress signals
may be encountered by a developing tumor. Activation of
p53 can induce several responses in cells, including diffe-
rentiation, senescence, DNA repair and the inhibition of an-
giogenesis [10].
We tested the hypothesis that expression of matrix metal-
loproteinase-1 (MMP1), osteopontin (OPN) could also aug-
ment lesion periosteum or periodontal membrane.
Osteopontin (OPN) is biosynthesized by a variety of tis-
sue types including fibroblasts, preosteoblasts, osteoblasts,
osteocytes, odontoblasts, some bone marrow cells [11].
OPN which works as a cytokine, function as an extracellu-
lar matrix protein, protein against apoptosis and induce sur-
vival and proliferation in several cell types. OPN has a pro-
survival and/or proliferative function in adherent cell types
such as epithelial cells [11].
Matrix metalloproteinases (MMPs) secreted by cervical
and ovarian cancer, especially MMP-2 and MMP-9, play
crucial roles in tumor invasion and metastasis. Sutinen M et
al [12] reported the release of MMP1 by human normal and
transformed fibroblasts, chondrocytes, epithelial cells, mac-
rophages. They showed that active MMP1 splitting by col-
lagen I, VII, X. However, the mechanism of MMP1 activa-
tion was not elucidated in giant-cell epulis and degradation
of extracellular periosteum or periodontal membrane mat-
rix.
So it is necessary to understand the cellular mechanism of
giant-cell epulisinfiltrate the alveolar bone. 
In the present work, we show the expression of MGMT,
p53, OPN and MMP-1 in giant-cell epulis. There have been
no reports about expression of MGMT, p53, OPN and
MMP-1 in giant-cell epulis.
Methods
The study population included 10 patients with giant-cell
epulis. Only patients with available tissue represent a subset
of the overall study cohorts.
Hematoxylin and eosin (H&E) stains have been used for
at least a century and are still essential for recognizing va -
rious tissue types and the morphologic change. Paraffin sec-
tions are immersing into three sets of xylene for 10 minutes
each followed by three sets of absolute ethanol for 10 minu-
tes and finally rinsed with tap water. Slides are placed into
haematoxylin for 5 minutes and rinsed thoroughly under tap
water for approximately 4–5 minutes. Excess haematoxylin
is removed by adding 1% acid alcohol (1% HCl in 70%
(v/v) alcohol) for 5 seconds followed by a tap water wash.
The slides are rinsed in tap water before being stained in eo-
sin (1% (w/v)) for 15 seconds with a subsequent wash in
running tap water for 1–5 minutes. The slides are covered
with glass cover slips.
Immunostainings for MGMT, p53, OPN and MMP-1 we-
re performed on formalin-fixed (pH 7,4), paraffin-embed-
ded Giant-cell epulis tissue sections using mouse monoclo-
nal anti- MGMT, anti-OPN, anti-MMP-1and anti- p53
(Thermo Fisher Scientific UK). Briefly, 4 μm thick tissue
sections were dewaxed in xylene and were brought to water
through graded alcohols. Antigen retrieval was performed
by microwaving slides in 10mM citrate buffer (pH 6.2) for
30 min at high power, according to the manufacturer’s in-
structions. To remove the endogenous peroxidase activity,
Figure 1
Giant-cell epulis, Haematoxylin and Eosin 
(x800 magnification) A – Areas of haemorrhages, 
B – Fibroblastic stroma, C – Giant cells
Figure 2
Expression of MGMT proteins in giant-cell epulis 
(x800 magnification) A – Giant cells MGMT “+”, 
B – Fibroblastic stroma MGMT “–”
A B C
A B
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sections were then treated with freshly prepared 1.0% hyd-
rogen peroxide in the dark for 30 min at 37 °C temperature.
Non-specific antibody binding was blocked using blocking
serum. The sections were incubated for 30 min, at 37  °C
temperature, with the primaries antibodies against MGMT,
p53, OPN and MMP-2 diluted 1 : 100 in phosphate buffered
saline (PBS) pH 7.2, After washing 3 times with PBS. Anti-
(mouse IgG)–horseradish peroxidase conjugate (1 : 40 000
dilution) was used for the detection of the MGMT, p53,
OPN and MMP–1 primaries antibodies, sections were then
incubated for 20 min, at 37 °C temperature. The colour was
developed by DAB.
Appearance of positive factors was detected semiquanti-
tatively by counting of positive structures in visual field
(- – 0, + – few, ++ – moderate, +++ – numerous, ++++ –
abundance positive structures in visual field).
Results
Peripheral giant cell epulis is shown in Figure  1.
Microscopic examination revealed tissue with giant-cell
(Figure 1C), fibrous connective tissue (Figure 1B), areas of
haemorrhages (Figure  1A) and few capillaries. There was
no sign of malignancy.
MGMT and p53 was expressed in giant-cell. Expression
of MGMT and p53 in giant-cell epulis is shown in Figures
2 and 3. Induction of the enzymatic activity of MGMT was
increased p53. This could be explained by the fact that
MGMT is physiologically expressed by the giant-cell of
epulis, p53 expression is weak or absent in giant-cell epulis
and non induced apoptosis in the fibrous connective tissue.
MMP-1 and OPN were expressed in all specimens. The
immunoexpression of these proteins was confirmed by the
presence of brown stained cytoplasm in giant-cell epulis.
MMP-1 was expressed in giant-cell and stromal cells at the
invasion front in all. In general, MMP-1 staining was more
intense in the giant-cell than in the stroma. 
By immunohistochemistry, 96.9 ± 0.5 % (P  <  0.05) of 
giant-cells were positive for MGMT, whereas only 5.67 ±
0.32 % of giant-cells were positive for p53 (P < 0.05).
With respect to the immunoexpression of MMP-1 in 
giant-cell, 75,9 ± 1.33 % (P < 0.01) positive cells. In the
stroma, immunoreactivity of MMP-1 was classified with
a score of 9 in most cases 54.12 ± 1.36 % (P  <  0.05)
(Figure 5).OPN was expressed in giant-cell at the invasion
front in all specimens analyzed. With respect to the immu-
noexpression of OPN in the giant-cell of epulis 10
(15.77 ± 1.8 % P > 0.05) cases (Figure 4) In the stroma, im-
munoreactivity of OPN was in cases 0 %.
Discussion
The results of this study demonstrate giant-cell expressi-
on of p53 or MGMT in human.
The role of MGMT proteins in response to DNA damage
can be inferred from the interactions of MGMT proteins
with the tumor suppressor protein, p53, and p53-related pro-
teins. p53 acts as a major point in a complex network that
responds to diverse cellular stresses, including DNA dama-
ge [13, 14].
In precancerous oral lesions, significant loss of MGMT
expression was noted from hyperplasia to dysplasia, sup-
porting the assumption that MGMT deregulation may be an
early event in oral tumorogenesis [15].
Type I collagen, responsible for connective tissue strength
and rigidity, is the main bone organic matrix component
[16] and MMP-1 is one of the proteases that can degrade the
triple-helical domain of type I fibrillar collagen [15]. The
presence of MMP-1 in giant-cell epulis may be associated
with the degradation of the organic bone matrix [17]. The
Figure 3
Expression of p53 proteins in giant-cell epulis, 
(x800 magnification) A – Giant cells p53 “–”, 
B – Giant cells p53 “+”, C – Fibroblastic stroma p53 “–”
Figure 4
Expression of OPN proteins in giant-cell epulis
(x800 magnification) A – Fibroblastic stroma OPN “-”, 
B – Areas of haemorrhages, C – Giant cells OPN “+”
A B C
A B C
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present study showed that giant-cell and stromal cells studi-
ed produced MMP-1. However, expression was higher in the
parenchyma. It is believed that these stromal enzymes po-
tentiate the action of MMPs produced by the parenchyma.
This fact supports the view of an interaction between neo-
plastic cells and the adjacent stroma as demonstrated in so-
me experiments [18]. This strategic interaction permits neo-
plastic cells to induce stromal cells to produce proteolytic
enzymes that act in synergism with tumor enzymes, thus fa-
cilitating the processes of invasion in bone matrix.
We have previously shown that osteopontin expositive
epulis. The osteopontin pattern of distribution was in the
form of diffuse granular cytoplasmic reactivity and, more
rarely, of paranuclear dots in the Golgi area [19]. This in -
creased in association with interstitial macrophage infiltra-
tion [20]. Kelly L et al [21] demonstrated a pattern of focal
strong osteopontin expression in association with very focal
macrophage accumulations. This may reflect localized is-
chemia induced by the vasoconstrictive effects. Increased
osteopontin levels have been detected in the plasma or se-
rum derived from patients with a number of solid neo-
plasms, head and neck [22]. Thus, OPN expression appears
to affect the biological behavior of giant-cell epulis, and this
effect depends on the anatomical origin of the tumor. These
results indicate that determination of the prognosis of pati-
ents with giant-cell epulis should consider OPN expression. 
Conclusion
MGMT, MMP-1, p53 and OPN may play important roles
in the biology of giant-cell epulis. Presence of reparative en-
zyme MGMT indicate benign variant of tumor process due
to the possibility reparation pathologically alkylated guani-
ne.MMP-1 in giant-cell epulis may help to explain invasion
in bone matrix.
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Figure 5
Expression of MMP-1 proteins in giant-cell epulis 
(x800 magnification) A – Giant cells MMP-1 “+”, 
B – Fibroblastic stroma MMP-1 “–”, 
C – Giant cells MMP-1 “+++”
A AB C
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